Press Releases
Press Releases
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection 100 mg/vial in India for Restricted Emergency Use in COVID-19 Patients
Mylan N.V. announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI's accelerated approval process to address urgent, unmet needs amid the evolving...
Press Releases
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the U.S. FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The...
Drug Research
Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market
With drug development growing increasingly complex and cost-intensive, biopharmaceutical companies are under significant pressure to streamline their products’ path to market. The desired goal of the collaboration is to create long-term value through the alignment of manufacturing approaches that...
Clinical Trials
Zydus vaccine for COVID-19 (ZyCoV-D) successfully completes preclinical development and receives permission to initiate human clinical trials
Zydus an innovation-driven, global pharmaceutical company, announced that it's plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its Vaccine Technology Centre in Ahmedabad, India has successfully completed the preclinical phase and has now received permission from the...
Drug Research
BioInvent extends research collaboration and license agreement with Pfizer Inc
BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until the end of 2020.
In December 2016, the companies entered into the agreement for the...
Press Releases
Fujifilm partners with Dr. Reddys and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
FUJIFILM Corporation partners with Dr. Reddy's Laboratories Ltd., a global pharmaceutical company headquartered in India and Global Response Aid, a global provider of medical supplies and pharmaceuticals, aimed at overseas deployment of a treatment drug for the novel coronavirus...
Packaging & Labelling
Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility, Significantly Increasing Capacity
Grand River Aseptic Manufacturing, an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
With the opening of its large-scale fill/finish facility GRAM more than tripled its existing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















